Data Sheet 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.docx by Yi Li (1144)

“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”

Metabolism of lipids and lipid proteins CKO vs K5Cre Reactome by Kevin J. Mills (9270966)

Subjects:

Ceramide biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

Subjects:

UHPLC-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Uncropped raw western blot images. by Kevin J. Mills (9270966)

Subjects:

LC-IMS-CID-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Phospholipid metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

Subjects:

Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”

PRISMA flow chart. by Filip Stanicic (17808254)

“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”

Data Sheet 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.docx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Stable incorporation of p53 lentiplasmids is detectible and does not impact cellular growth rates. by Nathaniel C. Holcomb (22793595)

Cumulative MARV shedding in bats from the SOSV-MARV and KASV-MARV experimental cohort. by Amy J. Schuh (8520354)

Subjects:

MARV shedding dynamics in bats from the KASV-MARV experimental cohort. by Amy J. Schuh (8520354)

Subjects:

Experimental design. by Amy J. Schuh (8520354)

Subjects: